Hbk Sorce Advisory LLC Eli Lilly & CO Transaction History

Hbk Sorce Advisory LLC

  • $2.56 Billion
  • Q3 2024

A detailed history of Hbk Sorce Advisory LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Hbk Sorce Advisory LLC holds 18,859 shares of LLY stock, worth $14.9 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
18,859
Previous 19,171 1.63%
Holding current value
$14.9 Million
Previous $17.4 Million 3.74%
% of portfolio
0.65%
Previous 0.65%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$772.14 - $960.02 $240,907 - $299,526
-312 Reduced 1.63%
18,859 $16.7 Million
Q2 2024

Aug 08, 2024
SELL
$724.87 - $909.04 $258,053 - $323,618
-356 Reduced 1.82%
19,171 $17.4 Million
Q1 2024

May 09, 2024
BUY
$592.2 - $792.28 $479,089 - $640,954
809 Added 4.32%
19,527 $15.2 Million
Q4 2023

Jan 25, 2024
SELL
$525.19 - $619.13 $851,858 - $1 Million
-1,622 Reduced 7.97%
18,718 $10.9 Million
Q3 2023

Nov 06, 2023
SELL
$434.7 - $599.3 $385,144 - $530,979
-886 Reduced 4.17%
20,340 $10.9 Million
Q2 2023

Aug 04, 2023
SELL
$350.74 - $468.98 $4.98 Million - $6.66 Million
-14,210 Reduced 40.1%
21,226 $9.95 Million
Q1 2023

Aug 15, 2023
BUY
$310.63 - $364.82 $48,458 - $56,911
156 Added 0.73%
21,382 $7.34 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $1.71 Million - $2 Million
-5,494 Reduced 13.42%
35,436 $19.2 Million
Q4 2022

Feb 09, 2023
BUY
$321.55 - $374.67 $7.86 Million - $9.16 Million
24,445 Added 148.29%
40,930 $15 Million
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $12,452 - $14,190
42 Added 0.26%
16,485 $5.33 Million
Q2 2022

Aug 15, 2022
SELL
$278.73 - $327.27 $1.39 Million - $1.63 Million
-4,972 Reduced 23.22%
16,443 $5.33 Million
Q1 2022

May 13, 2022
SELL
$234.69 - $291.66 $293,597 - $364,866
-1,251 Reduced 5.52%
21,415 $6.13 Million
Q4 2021

Feb 15, 2022
BUY
$224.85 - $279.04 $241,039 - $299,130
1,072 Added 4.96%
22,666 $6.26 Million
Q3 2021

Nov 15, 2021
BUY
$221.6 - $272.71 $44,320 - $54,541
200 Added 0.93%
21,594 $4.99 Million
Q2 2021

Aug 12, 2021
BUY
$180.55 - $233.54 $284,005 - $367,358
1,573 Added 7.94%
21,394 $4.91 Million
Q1 2021

May 14, 2021
SELL
$164.32 - $212.72 $412,771 - $534,352
-2,512 Reduced 11.25%
19,821 $3.7 Million
Q4 2020

Feb 12, 2021
SELL
$130.46 - $172.63 $51,792 - $68,534
-397 Reduced 1.75%
22,333 $3.77 Million
Q3 2020

Nov 13, 2020
SELL
$146.22 - $169.13 $238,631 - $276,020
-1,632 Reduced 6.7%
22,730 $3.37 Million
Q2 2020

Aug 14, 2020
BUY
$136.42 - $164.18 $106,544 - $128,224
781 Added 3.31%
24,362 $4 Million
Q1 2020

May 15, 2020
SELL
$119.05 - $147.35 $12,024 - $14,882
-101 Reduced 0.43%
23,581 $3.27 Million
Q4 2019

Feb 13, 2020
BUY
$106.92 - $132.43 $6,735 - $8,343
63 Added 0.27%
23,682 $3.11 Million
Q3 2019

Nov 14, 2019
BUY
$106.79 - $116.16 $423,742 - $460,922
3,968 Added 20.19%
23,619 $2.64 Million
Q2 2019

Aug 15, 2019
BUY
$110.79 - $129.32 $816,633 - $953,217
7,371 Added 60.02%
19,651 $2.18 Million
Q2 2019

Aug 14, 2019
SELL
$110.79 - $129.32 $836,907 - $976,883
-7,554 Reduced 38.09%
12,280 $967,000
Q1 2019

May 13, 2019
BUY
$111.31 - $131.02 $19,145 - $22,535
172 Added 0.87%
19,834 $2.57 Million
Q4 2018

Feb 14, 2019
BUY
$105.9 - $118.64 $50,726 - $56,828
479 Added 2.5%
19,662 $2.28 Million
Q3 2018

Nov 15, 2018
SELL
$85.86 - $107.31 $9,187 - $11,482
-107 Reduced 0.55%
19,183 $2.06 Million
Q2 2018

Aug 10, 2018
SELL
$75.7 - $86.88 $9,235 - $10,599
-122 Reduced 0.63%
19,290 $0
Q1 2018

May 15, 2018
SELL
$74.21 - $87.6 $176,694 - $208,575
-2,381 Reduced 10.93%
19,412 $1.5 Million
Q4 2017

Feb 15, 2018
BUY
$81.94 - $87.89 $560,469 - $601,167
6,840 Added 45.74%
21,793 $1.84 Million
Q3 2017

Nov 14, 2017
BUY
$77.07 - $85.54 $1.15 Million - $1.28 Million
14,953
14,953 $1.28 Million

Others Institutions Holding LLY

# of Institutions
4,007
Shares Held
752M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hbk Sorce Advisory LLC Portfolio

Follow Hbk Sorce Advisory LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Sorce Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Sorce Advisory LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email